Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004087524 | SCV003545213 | uncertain significance | not specified | 2021-09-30 | criteria provided, single submitter | clinical testing | The c.5927T>C (p.I1976T) alteration is located in exon 38 (coding exon 38) of the HMCN1 gene. This alteration results from a T to C substitution at nucleotide position 5927, causing the isoleucine (I) at amino acid position 1976 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003108161 | SCV003783917 | uncertain significance | not provided | 2022-12-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with HMCN1-related conditions. This variant is present in population databases (rs372669405, gnomAD 0.01%). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1976 of the HMCN1 protein (p.Ile1976Thr). |
Genome- |
RCV003455750 | SCV004179793 | uncertain significance | Age related macular degeneration 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |